With our Accelerated Strain Advancement Platform (ASAP™) we provide our global partners with a versatile, low-cost and sustainable means to increase product yields and/or develop novel, high value, optimized ingredients for use in the nutrition, personal care and flavor and fragrance industries.
With ASAP, we combine our proprietary and highly differentiated suite of precision gene-editing technologies, RTDS™, extensive fermentation expertise, and specialized downstream processing know-how for the efficient development and optimization of targeted traits in microorganisms.
“Our strategy at Nucelis is to build a partnering business with customers who want an efficient and economically viable path
to new non-transgenic micro-organism strains that deliver improved performance.”
— SEAN P. O’CONNOR, CEO NUCELIS